Bradley Stohr

Bradley Stohr is a faculty member in the Department of Pathology at the University of California, San Francisco (UCSF) School of Medicine. He holds an MD and PhD, with clinical training in Anatomic Pathology and research experience in biochemistry and cancer genomics. His work focuses on molecular pathology of genitourinary cancers, particularly prostate, bladder, and kidney tumors.

Dr. Stohr’s research interests include:

• Molecular profiling of genitourinary cancers
• Next-generation sequencing in diagnostic pathology
• Immunohistochemistry and biomarker discovery
• Cancer evolution and clonal dynamics
• Integration of genomic classifiers with histologic assessment

His recent publications (2024–2025) reveal a strong focus on applying advanced molecular techniques to improve cancer diagnosis, risk stratification, and therapeutic targeting. These works frequently involve collaboration with multidisciplinary teams at UCSF and cover topics such as Decipher scoring, PTEN loss, DNA damage repair mutations, and single-cell analysis in bladder cancer. The research demonstrates a translational emphasis, bridging laboratory findings with clinical pathology applications.

His scientific awards include:

• Phi Beta Kappa (1995)
• Sigma Xi (1996–2003)
• Medical Scientist Training Program Fellowship
• American Cancer Society Postdoctoral Fellowship
• NIH Mentored Clinical Scientist Development Award (K08)

Dr. Stohr has been involved in significant research grants, including as Principal Investigator on an NIH-funded project (K08CA134552) on telomere disruption in cancer and stem cells. While no formal advisees are listed, his collaborative publications suggest active mentorship and team-based research. He is associated with the Helen Diller Family Comprehensive Cancer Center (HDFCCC) at UCSF, contributing to a robust research environment in cancer biology and precision oncology.